Blood test for pregnancy risk assessment using fetal cells
Part of Blood & lymphatic, Bones, joints & muscles, Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study tests a new blood test that looks for fetal cells in your bloodstream to check your baby's health during pregnancy. The test is non-invasive—just a regular blood draw—and aims to help identify pregnancy risks earlier than traditional methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be pregnant and between 10 and 20 weeks along (roughly 2.5 to 5 months)
- You are carrying one baby, not twins or multiples
- You do not have active cancer requiring current treatment
- You are willing to have a blood sample drawn for research testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a new blood test to screen for single-gene disorders (conditions caused by changes in one gene) during pregnancy. It may help if you or your baby's father carry a genetic disorder, or if an ultrasound shows signs of a possible genetic condition.
This study tests a new blood test during early pregnancy that can screen for certain genetic conditions by analyzing fetal cells. A simple blood draw may help detect potential chromosomal abnormalities earlier and more safely than traditional methods.
This study looks at a simple blood test that can check the unborn baby's DNA during pregnancy. It may help doctors learn more about the baby's health without any risk to you or the baby.
This study tests a new blood test that can screen for genetic problems in babies during pregnancy. It may find more conditions than standard tests, especially for pregnancies with certain ultrasound findings or other risk factors.
This study collects genetic samples from pregnant people who have a higher chance of chromosome changes in the baby. It tests whether taking samples through CVS and/or amniocentesis can help understand the baby’s genetic makeup.
This study tests a new method to detect genetic information from a pregnancy as early as 7 weeks, using cells from the placenta. It may help identify certain genetic conditions earlier than standard tests.
Hear when a new Aneuploidy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.